PT - JOURNAL ARTICLE AU - Juvekar, Parikshit AU - Dorent, Reuben AU - Kögl, Fryderyk AU - Torio, Erickson AU - Barr, Colton AU - Rigolo, Laura AU - Galvin, Colin AU - Jowkar, Nick AU - Kazi, Anees AU - Haouchine, Nazim AU - Cheema, Harneet AU - Navab, Nassir AU - Pieper, Steve AU - Wells, William M. AU - Bi, Wenya Linda AU - Golby, Alexandra AU - Frisken, Sarah AU - Kapur, Tina TI - ReMIND: The Brain Resection Multimodal Imaging Database AID - 10.1101/2023.09.14.23295596 DP - 2024 Jan 01 TA - medRxiv PG - 2023.09.14.23295596 4099 - http://medrxiv.org/content/early/2024/04/08/2023.09.14.23295596.short 4100 - http://medrxiv.org/content/early/2024/04/08/2023.09.14.23295596.full AB - The standard of care for brain tumors is maximal safe surgical resection. Neuronavigation augments the surgeon’s ability to achieve this but loses validity as surgery progresses due to brain shift. Moreover, gliomas are often indistinguishable from surrounding healthy brain tissue. Intraoperative magnetic resonance imaging (iMRI) and ultrasound (iUS) help visualize the tumor and brain shift. iUS is faster and easier to incorporate into surgical workflows but offers a lower contrast between tumorous and healthy tissues than iMRI. With the success of data-hungry Artificial Intelligence algorithms in medical image analysis, the benefits of sharing well-curated data cannot be overstated. To this end, we provide the largest publicly available MRI and iUS database of surgically treated brain tumors, including gliomas (n=92), metastases (n=11), and others (n=11). This collection contains 369 preoperative MRI series, 320 3D iUS series, 301 iMRI series, and 356 segmentations collected from 114 consecutive patients at a single institution. This database is expected to help brain shift and image analysis research and neurosurgical training in interpreting iUS and iMRI.Competing Interest StatementThe authors have declared no competing interest.Funding StatementR01EB032387, R01EB027134, P41EB015902, and P41EB028741.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of Mass General Brigham, Boston, MA gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced are available online at https://doi.org/10.7937/3rag-d070 https://doi.org/10.7937/3rag-d070